{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:58:58Z","timestamp":1790830738810,"version":"4.1.0"},"reference-count":0,"publisher":"International Union Against Tuberculosis and Lung Disease","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["int j tuberc lung dis"],"published-print":{"date-parts":[[2026,9,30]]},"abstract":"<sec><title>BACKGROUND<\/title>Rapid adoption and scale-up of new anti-TB regimens requires evidence on efficacy and safety, but also on end-user preferences, implementation barriers, regulatory hurdles, and local conditions. The aim of this study is to describe\n the extent to which the questions included in a global end-user survey address priority research questions identified through a Delphi process.<\/sec><sec><title>METHODS<\/title>We used a methodological mapping approach to examine the extent to which questions\n included in a TB survey and interviews to patients, health care workers, and experts align with seven research questions identified through a recent Delphi process. The content of the survey and interviews was systematically compared and matched against the priority research questions to assess\n its analytical capacity.<\/sec><sec><title>RESULTS<\/title>The survey contains data relevant to all seven research questions: three with full analytical capacity; three with substantial but incomplete capacity; and one with partial capacity.<\/sec><sec><title>CONCLUSION<\/title>Mapping\n and matching exercise indicates that the FAST-TB survey and structured interviews can help identify where additional qualitative, economic, or policy research will be needed to support new regimen development, adoption, and scale-up.<\/sec><\/jats:p>","DOI":"10.5588\/ijtld.26.0442","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:32:57Z","timestamp":1790829177000},"page":"427-435","source":"Crossref","is-referenced-by-count":0,"title":["Results of the FAST-TB end-users\u2019 survey align with priority research questions on new TB treatment regimens"],"prefix":"10.5588","volume":"30","author":[{"given":"A.","family":"Bellavia","sequence":"first","affiliation":[{"name":"Department of Health Promotion Mother and Child Care, Internal Medicine, University of Palermo; U.O.C. Astanteria\/MCAU, Paolo Giaccone, Palermo, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.A.","family":"Refera","sequence":"additional","affiliation":[{"name":"St. Mary Catholic Primary Hospital, Dubbo, Areka, Ethiopia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.R.","family":"Silva","sequence":"additional","affiliation":[{"name":"Faculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Kherabi","sequence":"additional","affiliation":[{"name":"Infectious and Tropical Diseases Department, Bichat-Claude Bernard Hospital, Assistance Publique H\u00f4pitaux de Paris, Universit\u00e9 Paris Cit\u00e9, Paris, France;, Universit\u00e9 Paris Cit\u00e9, Inserm, IAME, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Singla","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Public Health, National Institute of TB & Respiratory Diseases, New Delhi, India;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Permata","sequence":"additional","affiliation":[{"name":"Yayasan Healthica, Jakarta, Indonesia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.C.","family":"Teixeira","sequence":"additional","affiliation":[{"name":"National Institute of Respiratory Diseases and the Environment (INERAM), Asunci\u00f3n, Paraguay;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Pontali","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Galliera Hospital, Genova, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Fumagalli","sequence":"additional","affiliation":[{"name":"Regional TB Reference Centre and Laboratory, Villa Marelli Institute, ASST Grande Ospedale Metropolitano Niguarda, Milan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Lagrutta","sequence":"additional","affiliation":[{"name":"Universidad de Buenos Aires, Instituto de Tisioneumonologia Profesor Doctor Ra\u00fal Vaccarezza, Buenos Aires, Argentina;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Munoz-Torrico","sequence":"additional","affiliation":[{"name":"Cl\u00ednica de Tuberculosis, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico City, Mexico;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rifat","sequence":"additional","affiliation":[{"name":"Damien Foundation, Dhaka, Bangladesh;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.B.","family":"Souleymane","sequence":"additional","affiliation":[{"name":"Damien Foundation, Niamey, Niger;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Villa","sequence":"additional","affiliation":[{"name":"Department Biomedical Sciences for Health, School of Public Health, University of Milan, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lienhardt","sequence":"additional","affiliation":[{"name":"French Institute for Research on Sustainable Development (IRD), Montpellier, France;, FAST-TB, CRDF Global, Arlington, VA, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Centis","sequence":"additional","affiliation":[{"name":"Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"D\u2019Ambrosio","sequence":"additional","affiliation":[{"name":"Public Health Consulting Group, Lugano, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.","family":"Raviglione","sequence":"additional","affiliation":[{"name":"FAST-TB, CRDF Global, Arlington, VA, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.B.","family":"Migliori","sequence":"additional","affiliation":[{"name":"Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3554","container-title":["The International Journal of Tuberculosis and Lung Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ingentaconnect.com\/content\/iuatld\/ijtld\/2026\/00000030\/00000010\/art00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:33:23Z","timestamp":1790829203000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ingentaconnect.com\/content\/10.5588\/ijtld.26.0442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":0,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,9,30]]}},"alternative-id":["1027-3719(20260930)30:10L.427;1-"],"URL":"https:\/\/doi.org\/10.5588\/ijtld.26.0442","relation":{},"ISSN":["1027-3719"],"issn-type":[{"value":"1027-3719","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,30]]}}}